"The Notoginseng Extract Market was valued at USD 180.4 million in 2026 and is projected to reach $ 300.5 million by 2034, growing at a CAGR of 7.56%."
The Notoginseng Extract Market is a specialized segment of botanical extracts, herbal nutraceuticals, traditional medicine ingredients, functional supplements, natural antioxidants, pharmaceutical raw materials, cosmetic actives, and plant-based wellness ingredients, serving dietary supplement manufacturers, traditional medicine companies, pharmaceutical formulators, functional food brands, personal care companies, herbal product retailers, and health-conscious consumers. Notoginseng extract is derived mainly from the roots of Panax notoginseng, also known as Sanqi or Tianqi, and is valued for its naturally occurring saponins, including notoginsenosides and ginsenosides. The extract is used in capsules, tablets, powders, granules, tinctures, functional beverages, herbal blends, topical formulations, and traditional medicine preparations. Key application areas include cardiovascular wellness, blood circulation support, anti-inflammatory positioning, antioxidant formulations, immune wellness, fatigue management, sports recovery, women’s health products, skincare products, and age-related wellness supplements. Scientific reviews identify Panax notoginseng saponins as major active constituents associated with multiple pharmacological research areas, including cardiovascular, inflammatory, metabolic, and neurological health studies.
The market is gaining traction as consumers increasingly prefer plant-based, traditional, clean-label, and preventive health products. Demand is supported by rising interest in herbal extracts, Asian traditional medicine systems, natural circulation-support supplements, botanical antioxidants, and multifunctional wellness ingredients. Notoginseng extract is increasingly used in standardized extract formats where manufacturers focus on active saponin content, purity, traceability, solvent control, and consistent bioactive profiles. Key trends include higher demand for standardized Panax notoginseng saponins, expansion of capsule and powder supplements, increasing use in combination herbal formulas, growing interest in functional beverages, premium botanical sourcing, and wider e-commerce distribution. However, challenges include raw material supply fluctuations, quality adulteration risk, inconsistent standardization, regulatory limitations on health claims, limited consumer awareness outside Asia, price pressure from lower-grade extracts, and the need for stronger clinical validation. The competitive landscape includes botanical extract manufacturers, traditional Chinese medicine companies, nutraceutical ingredient suppliers, contract supplement manufacturers, herbal medicine brands, and specialty plant extract exporters.
North America Notoginseng Extract Market is developing through rising demand for botanical supplements, traditional herbal ingredients, natural circulation-support products, antioxidant formulations, and preventive wellness solutions. The United States remains the key demand center, supported by strong dietary supplement consumption, e-commerce wellness brands, natural product retailers, integrative health practitioners, and growing interest in Asian herbal ingredients. Demand is emerging in capsules, powders, tinctures, herbal blends, and combination formulas targeting cardiovascular wellness, recovery, vitality, healthy aging, and inflammation-related positioning. However, the market remains more niche compared to ginseng, turmeric, ashwagandha, and other better-known botanicals. Growth opportunities depend on consumer education, standardized saponin content, clean-label positioning, third-party testing, and responsible health-claim communication. Regulatory scrutiny around disease claims and limited mainstream awareness remain key challenges for suppliers and supplement brands.
Asia Pacific Notoginseng Extract Market is the strongest regional market, led by China due to the long-established use of Panax notoginseng, also known as Sanqi or Tianqi, in traditional Chinese medicine. The plant is primarily associated with Southwest China, particularly Yunnan, and scientific literature identifies it as a widely used traditional Chinese medicinal herb with applications linked to cardiovascular, inflammatory, metabolic, and neurological research areas. China dominates both raw material supply and traditional product demand, while Japan, South Korea, India, Southeast Asia, and Australia contribute through herbal supplements, nutraceuticals, functional foods, and premium botanical wellness products. Regional manufacturers focus on standardized saponin extracts, powder extracts, granules, capsules, and traditional medicine formulations. Opportunities are strong in modernized traditional medicine, e-commerce herbal products, clinical-style nutraceuticals, and functional beverages. However, raw material quality, cultivation constraints, adulteration risk, pesticide control, and batch consistency remain important concerns.
Europe Notoginseng Extract Market is shaped by demand for premium botanical ingredients, natural wellness products, clean-label supplements, herbal extracts, and antioxidant formulations. Germany, the United Kingdom, France, Italy, Spain, the Netherlands, and Nordic countries are important markets due to consumer interest in preventive health, pharmacy-distributed supplements, herbal medicine traditions, and scientifically supported natural ingredients. Notoginseng extract is used mainly in capsules, tablets, powders, and combination botanical formulations for circulation support, vitality, healthy aging, and recovery-oriented wellness positioning. European buyers typically emphasize traceability, botanical authentication, active compound standardization, contaminant testing, sustainability, and regulatory compliance. The market offers opportunities for high-quality standardized extracts and premium Asian botanicals, but growth is limited by lower consumer awareness compared with more established botanicals such as Panax ginseng, ginkgo, turmeric, and milk thistle. Strict health-claim regulations and documentation requirements also increase entry barriers for suppliers.
Middle East & Africa Notoginseng Extract Market is at an early development stage, supported by rising demand for imported dietary supplements, premium herbal products, traditional wellness ingredients, and natural antioxidant formulations. Gulf countries offer the strongest opportunities due to modern pharmacy chains, high-income wellness consumers, specialist clinics, online supplement retail, and growing demand for premium nutraceuticals. Demand is mainly concentrated in capsules, tablets, herbal blends, and imported finished supplements rather than large-scale local extraction. South Africa also contributes through health stores, e-commerce platforms, and natural wellness retail channels. Opportunities exist in halal-certified botanical supplements, clean-label products, cardiovascular wellness formulations, and premium herbal blends. However, limited consumer familiarity, import dependence, price sensitivity, regulatory variation, and weak local raw material availability restrict broader market penetration. Supplier success depends on trusted quality documentation, localized education, and distribution partnerships with pharmacies and wellness retailers.
South & Central America Notoginseng Extract Market is gradually emerging through the wider adoption of nutraceuticals, herbal supplements, natural antioxidants, and plant-based wellness products. Brazil, Mexico, Argentina, Chile, and Colombia are key potential markets due to growing supplement use, pharmacy retail expansion, online wellness channels, and rising interest in natural preventive health products. Notoginseng extract demand is mainly linked to imported supplements and botanical blends positioned around circulation support, vitality, recovery, and healthy aging. The market remains niche because consumer recognition of Sanqi or Tianqi is relatively low compared with ginseng, maca, guarana, turmeric, green tea extract, and other familiar botanicals. Opportunities are strongest for standardized extracts, practitioner-recommended herbal products, and premium formulations supported by quality testing and clear consumer education. Challenges include economic volatility, import costs, limited local processing, affordability issues, and regulatory differences across national supplement markets.
| Parameter | Notoginseng Extract Market Detail |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Market Size-Units | USD billion |
| Market Splits Covered | By Product, By Application, By End User and By Technology |
| Countries Covered | North America (USA, Canada, Mexico) |
| Analysis Covered | Latest Trends, Driving Factors, Challenges, Trade Analysis, Price Analysis, Supply-Chain Analysis, Competitive Landscape, Company Strategies |
| Customization | 10% free customization (up to 10 analyst hours) to modify segments, geographies, and companies analyzed |
| Post-Sale Support | 4 analyst hours, available up to 4 weeks |
| Delivery Format | The Latest Updated PDF and Excel Data file |
By Product
- Powder
- Liquid
- Capsules
By Application
- Medicinal
- Nutraceutical
- Cosmetic
By End User
- Pharmaceuticals
- Food and Beverage
- Personal Care
By Technology
- Extraction
- Fermentation
By Geography
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Spain, Italy, Rest of Europe)
- Asia-Pacific (China, India, Japan, Australia, Vietnam, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
March 2026 – NuLiv Science highlighted new clinical research on AstraGin, an ingredient based on Astragalus and Panax saponins, showing improved amino acid absorption from whey protein and potential benefits for muscle function, healthy aging, and active nutrition applications. This supports broader use of Panax-derived saponin ingredients in sports nutrition and recovery-focused supplement formulations.
February 2026 – Researchers published new findings on Panax notoginseng saponins in acute ischemic stroke patients with obesity. The study analyzed individual patient data from the PANDA trial and reported improved functional outcomes in overweight, obese, and abdominal-obesity patient groups, strengthening the clinical research base around Panax notoginseng saponins.
December 2025 – A narrative review in Annals of Translational Medicine expanded the scientific discussion around Panax notoginseng’s anti-inflammatory effects. The review highlighted ongoing research into notoginseng extracts and ginsenosides for blood circulation support and cardiovascular protection, reinforcing its positioning in circulation and inflammation-related wellness products.
November 2025 – A Frontiers review summarized the clinical application of Panax notoginseng saponins in neurological disorders. The article noted that PNS is approved for clinical use in China in multiple dosage forms, with injections mainly used for neurological conditions such as cerebral hemorrhage and cerebral ischemia, supporting demand from pharmaceutical and traditional medicine channels.
October 2025 – A study in Nutrients examined steamed Panax notoginseng saponins for cyclophosphamide-induced anemia. The study reported that steamed Panax notoginseng saponins influenced gut microbiota, hepatointestinal immune defense, and anemia-related outcomes in mice, expanding R&D interest in processed notoginseng saponin fractions and rare saponin-enriched products.
September 2025 – Yunnan Baiyao continued expanding its traditional Chinese medicine and wider healthcare strategy. The company’s Panax notoginseng extracts maintained leading positions in their category, while Yunnan Baiyao strengthened upstream quality control through a full TCM resource chain, satellite imaging, and AI-assisted procurement for herb cultivation monitoring.
March 2025 – STEMREGEN Sport gained wider visibility in the active nutrition category through the 2025 Natural Choice Awards. The product features notoginseng as part of a recovery-focused formulation for muscle recovery, resilience, and endurance, indicating growing use of notoginseng in sports wellness and regenerative-support supplement positioning.
January 2025 – A secondary analysis of the PANDA study evaluated the efficacy and safety of Panax notoginseng saponins by age group. The study supported continued clinical interest in Xuesaitong soft capsules for acute ischemic stroke, helping strengthen the evidence base for pharmaceutical-grade Panax notoginseng saponin preparations.
The Global Notoginseng Extract Market is estimated to generate USD 180.4 million in revenue in 2026.
The Global Notoginseng Extract Market is expected to grow at a Compound Annual Growth Rate (CAGR) of 7.56% during the forecast period from 2026 to 2034.
The Notoginseng Extract Market is estimated to reach USD 300.5 million by 2034.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!